Table 3 |
||||||||||
|
MICs (μg/ml) of quinolones for different colonies of E coli KZM120 containing each of the plasmids pBS3.8, pBS3.25 and pBS3.13 |
||||||||||
|
Plasmids |
Antibiotics |
|||||||||
|
|
||||||||||
|
NAL |
NOR |
SPA |
CIP |
ENX |
LEV |
GAR |
GRP |
TRV |
MOX |
|
|
|
||||||||||
|
pGEM-T |
1 |
0.016 |
0.032 |
0.002 |
0.032 |
0.004 |
0.002 |
0.001 |
0.004 |
0.004 |
|
pBS3.8 1 |
1 |
0.032 |
0.032 |
0.008 |
0.064 |
0.016 |
0.032 |
0.008 |
0.032 |
0.016 |
|
pBS3.8 2 |
1 |
0.016 |
0.032 |
0.004 |
0.064 |
0.008 |
0.016 |
0.008 |
0.032 |
0.016 |
|
pBS3.8 3 |
1 |
0.016 |
0.032 |
0.004 |
0.064 |
0.008 |
0.016 |
0.008 |
0.032 |
0.016 |
|
pBS3.13 1 |
1 |
0.016 |
0.032 |
0.004 |
0.064 |
0.008 |
0.008 |
0.004 |
0.016 |
0.016 |
|
pBS3.13 2 |
1 |
0.016 |
0.032 |
0.004 |
0.064 |
0.008 |
0.002 |
0.002 |
0.008 |
0.008 |
|
pBS3.13 3 |
1 |
0.016 |
0.032 |
0.004 |
0.064 |
0.008 |
0.002 |
0.002 |
0.008 |
0.008 |
|
pBS3.25 1 |
1 |
0.016 |
0.032 |
0.004 |
0.064 |
0.008 |
0.064 |
0.016 |
0.032 |
0.032 |
|
pBS3.25 2 |
1 |
0.016 |
0.032 |
0.004 |
0.064 |
0.008 |
0.008 |
0.004 |
0.016 |
0.008 |
|
pBS3.25 3 |
1 |
0.016 |
0.032 |
0.004 |
0.064 |
0.008 |
0.008 |
0.004 |
0.016 |
0.008 |
|
|
||||||||||
|
Three colonies were tested for each plasmid. NAL; nalidixic acid, NOR; norfloxacin, SPA; sparfloxacin, CIP; ciprofloxacin, ENX; enoxacin, LEV; levofloxacin, GAR; garenoxacin, GRP; grepafloxacin, TRV; trovafloxacin, MOX; moxifloxacin. |
||||||||||
|
Sánchez et al. BMC Microbiology 2008 8:148 doi:10.1186/1471-2180-8-148 |
||||||||||
